Congressional Testimony 2015

This section includes testimony by FDA officials before House and Senate Committees and Subcommittees.

November 2015

11/17/2015 Remarks of Nominee to be Commissioner of the Food and Drug Administration
Robert M. Califf, M.D., before the Senate Committee on Health, Education, Labor, and Pensions
11/17/2015 Examining the Regulation of Diagnostic Tests and Laboratory Operations
Jeffrey Shuren, M.D., J.D., before the House Subcommittee on Health, Committee on Energy and Commerce

10/21/2015 FDA's Regulatory Program for Foods Derived from Genetically Engineered Sources
Susan Mayne, Ph.D., Before the Committee on Agriculture, Nutrition and Forestry

09/17/2015 Biosimilar Implementation: A Progress Report from FDA
Janet Woodcock, M.D., before the Senate Committee on Health, Education, Labor and Pensions

06/24/2015 Cannabidiol: Barriers to Research and Potential Medical Benefits
Douglas C. Throckmorton, M.D., before the Senate Caucus on International Narcotics Control

05/06/2015 The Safety of Seafood Imports
Steven M. Solomon, D.V.M., M.P.H., before the Senate Committee on Small Business and Entrepreneurship
05/05/2015 Continuing America's Leadership: Realizing the Promise of Precision Medicine for Patients
Jeffrey Shuren, M.D., J.D., before the Senate Committee on Health, Education, Labor and Pensions
05/05/2015 Improving Management of the Controlled Substances Quota Process
CAPT Valerie Jensen, R.PH., before the Senate Caucus on International Narcotics Control
05/01/2015 What is the Federal Government Doing to Combat the Opioid Abuse Epidemic?
Douglas C. Throckmorton, M.D., before the House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

04/30/2015 Legislative Hearing on 21st Century Cures Janet Woodcock, M.D. and Jeffrey Shuren, M.D., J.D., before the House Committee on Energy and Commerce, Subcommittee on Health
04/28/2015 Continuing America's Leadership: The Future of Medical Innovation for Patients Jeffrey Shuren, M.D., J.D., before the Senate Committee on Health, Education, Labor and Pensions
04/28/2015 Continuing America's Leadership: The Future of Medical Innovation for Patients Janet Woodcock, M.D, before the Senate Committee on Health, Education, Labor, and Pensions

03/12/2015 The President's Fiscal Year 2016 Budget Request for FDA (Senate)
Margaret A. Hamburg, M.D., before the Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
03/10/2015 Continuing America’s Leadership in Medical Innovation for Patients
Margaret A. Hamburg, M.D., before the Senate Committee on Health, Education, Labor, and Pensions
03/04/2015 The President's Fiscal Year 2016 Budget Request for FDA (House of Representatives)
Margaret A. Hamburg, M.D., before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

02/26/2015 Medical and Public Health Preparedness and Response : Are We Ready for Future Threats?
Luciana Borio, M.D., before the Senate Committee on Health, Education, Labor and Pensions
02/03/2015 FDA’s Role in Preventing Influenza and Protecting the American Public Through Vaccination
Karen Midthun, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations